Ajanta Pharma Shares Decline 2.06% Amid Strong Quarterly and Annual Financial Growth
Ajanta Pharma's shares fell 2.06% to Rs 3,365.60 during Friday morning trade. The company, part of the Nifty Midcap 150 index, reported strong financial growth with quarterly revenue rising to Rs 1,625.96 crore and net profit increasing to Rs 334.22 crore in June 2026. Annually, revenue reached Rs 5,452.86 crore and net profit Rs 1,056 crore for the year ending March 2026, alongside a low debt-to-equity ratio of 0.05, indicating solid financial health.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (55/100). Lens Score 30/100.
Outlets measured: moneycontrol, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 31 Jul, 07:43 am. Other outlets followed.
- 1